Novo Nordisk grant to Pia Rantakari and Klaus Elenius
The Novo Nordisk Foundation awarded 2024 grants to five researchers from the University of Turku, totaling approximately €2,204,294.
Among the grant recipients were:
Docent, InFLAMES and Turku Bioscience group leader Pia Rantakari. Her research titled Unveiling the Role of Pituitary Gland Macrophages in Polycystic Ovarian Syndrome: Towards Novel Therapeutics got DKK 2.997.685 (approx. 401 988 €) funding.
Professor, BioCity Turku Director, Turku Bioscience group leader Klaus Elenius. His research titled Overcoming Cancer drUg Resistance by targeting ERBB3 (CURE) got DKK 5.981.741 (approx. 802 149 €) funding.
Warm congratulations!
Recent Posts
- Heidi Isokääntä Successfully Defends Dissertation on Gut Microbiome Development Heidi Isokääntä Successfully Defends Dissertation on Gut Microbiome Deveopment Turku, 26 September 2025 – Bioanalyst Read moreSeptember 29, 2025
- University of Jyväskylä to Award Honorary Doctorate to Johanna Ivaska The University of Jyväskylä will award 11 new honorary doctorates in May 2026. One of Read moreSeptember 26, 2025
- Turku Metabolomics Core Enhances MALDI Imaging with New Sprayer The Turku Metabolomics Core, part of the Turku Bioscience Centre, has acquired a SunCollect MALDI Read moreSeptember 19, 2025
- Christel Sourander Successfully Defends Her Thesis Congratulations! Christel Sourander successfully defended her thesis: “Identifying the effect of JNK on neural activity Read moreSeptember 9, 2025
- Researchers at Åbo Akademi University Discover a New Molecular Switch Regulating Breast Cancer Progression A research group led by our our affiliated group leader Professor Lea Sistonen at Åbo Read moreSeptember 4, 2025
- Autumn 2025 Frontiers of Science seminars start soon Frontiers of Science is a long-running seminar series, celebrating over 25 years of bringing internationally Read moreSeptember 3, 2025